부산대학교 도서관

Meulendijks, Didier ; Henricks, Linda M ; Sonke, Gabe S ; Deenen, Maarten J ; Froehlich, Tanja K ; Amstutz, Ursula ; Largiadèr, Carlo R ; Jennings, Barbara A ; Marinaki, Anthony M ; Sanderson, Jeremy D ; Kleibl, Zdenek ; Kleiblova, Petra ; Schwab, Matthias ; Zanger, Ulrich M ; Palles, Claire ; Tomlinson, Ian ; Gross, Eva ; van Kuilenburg, André B P ; Punt, Cornelis J A ; Koopman, Miriam ; Beijnen, Jos H ; Cats, Annemieke ; Schellens, Jan H M

In The Lancet Oncology December 2015 16(16):1639-1650

Böhm D; Department of Clinical Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands. doortje.bohm@catharinaziekenhuis.nl.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands. doortje.bohm@catharinaziekenhuis.nl.; Russ E; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Ziemons J; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Penders J; NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.; Department of Medical Microbiology, Infectious Diseases and Infection Prevention, Maastricht University Medical Centre, Maastricht, The Netherlands.; Smidt ML; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; van Best N; NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.; Department of Medical Microbiology, Infectious Diseases and Infection Prevention, Maastricht University Medical Centre, Maastricht, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Peeters SLJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre Leiden, the Netherlands.; Heersche N; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands.; Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Böhm D; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre Leiden, the Netherlands.; Böhringer S; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.; Guiljam R; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands.; Hulshof EC; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre Leiden, the Netherlands.; de Man FM; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands.; de With M; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands.; Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Joosse M; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Oomens G; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Wu QY; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre Leiden, the Netherlands.; Osman A; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Bins S; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands.; van Hellemond IEG; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, the Netherlands.; Verschoor AJ; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands.; Wumkes ML; Department of Medical Oncology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.; van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Thijs AM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre Leiden, the Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre Leiden, the Netherlands.

Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

van den Heuvel TBM; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. teun.vd.heuvel@catharinaziekenhuis.nl.; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands. teun.vd.heuvel@catharinaziekenhuis.nl.; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. teun.vd.heuvel@catharinaziekenhuis.nl.; Rauwerdink P; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.; Hulshof E; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; van de Vlasakker VCJ; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Pluimakers G; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Rovers KPB; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Burger PJWA; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; Nienhuijs SW; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Wiezer RJ; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.; Lurvink RJ; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Boerma D; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.; De Hingh IHJT; Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Hanrath MA; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Banken E; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; van den Wildenberg SAH; Department of Clinical Chemistry, Catharina Hospital, Eindhoven, the Netherlands.; Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.; van de Kerkhof D; Department of Clinical Chemistry, Catharina Hospital, Eindhoven, the Netherlands.; Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.; Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.; Boisdron-Celle M; Department of Oncopharmacology-Pharmacogenetics INSERM U892, Western Cancer Institute Paul Papin, Angers, France.; van den Bosch BJC; Department of Clinical Genetics, Clinical Genomics, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands.; Bax R; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Bet PM; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Maring JG; Department of Clinical Pharmacy, Isala, Zwolle, the Netherlands.; Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; van Hellemond IEG; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands. maarten.deenen@catharinaziekenhuis.nl.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands. maarten.deenen@catharinaziekenhuis.nl.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Temme PP; Department of Hospital Pharmacy, Meander Medical Centre, Amersfoort, the Netherlands. pp.temme@meandermc.nl.; van Luin M; Department of Hospital Pharmacy, Meander Medical Centre, Amersfoort, the Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Drug Analysis and Toxicology Division (KKGT) Section of the Dutch Foundation for Quality Assessment in Medical Laboratories (SKML), Nijmegen, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; Meijer R; Foundation for Quality Assessment in Medical Laboratory Diagnostics (SKML), Nijmegen, the Netherlands.; Jager NGL; Drug Analysis and Toxicology Division (KKGT) Section of the Dutch Foundation for Quality Assessment in Medical Laboratories (SKML), Nijmegen, the Netherlands.; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands.; Malingré MM; Department of Hospital Pharmacy, Meander Medical Centre, Amersfoort, the Netherlands.

Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE

Kicken MP; Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.; Bethlehem C; Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.; Beunen K; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.; de Jong P; Department of Pulmonology, Rijnstate Hospital, Arnhem, the Netherlands.; van Voorthuizen T; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.; van den Hudding JJ; Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, the Netherlands.; Moes DAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; and.; van Luin M; Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Clinical Pharmacy, Meander Medical Center, Amersfoort, the Netherlands.; Ter Heine R; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.; Smit HJM; Department of Pulmonology, Rijnstate Hospital, Arnhem, the Netherlands.; Filius PMG; Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, the Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; and.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE

Peeters SLJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Meulendijks D; Late Development Oncology, AstraZeneca, Cambridge, UK.; Kadric Z; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Ibrovic S; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Milosevic V; Department of Clinical Pharmacy, Elkerliek Hospital, Helmond, The Netherlands.; van de Poll M; Department of Clinical Pharmacy, Máxima Medical Centre, Eindhoven, The Netherlands.; Simkens LHJ; Department of Medical Oncology, Máxima Medical Centre, Eindhoven, The Netherlands.; Deiman BALM; Department of Molecular Biology, Catharina Hospital, Eindhoven, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Thijs AMJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Fiebrich-Westra HB; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; Haroun C; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; van der Galiën R; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; den Besten-Bertholee D; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; Deenen MJ; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; Moes DJAR; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; Bet PM; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; de Groot JWB; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; Brohet RM; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; van Kuilenburg ABP; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.; Maring JG; Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenburg, PhD, Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, NL, Jan Gerard Maring, PharmD, PhD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE; In Process

Kicken MP; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. mart.kicken@radboudumc.nl.; Department of Clinical Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands. mart.kicken@radboudumc.nl.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands.; van den Borne BEEM; Department of Pulmonology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.; Dumoulin DW; Department of Pulmonary Medicine, Erasmus Medical Center Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; van der Wekken AJ; Department of Pulmonology, University of Gronigen, University Medical Centre Groningen, Groningen, The Netherlands.; van den Heuvel MM; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.; Ter Heine R; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.

Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

de Rouw N; Department of Clinical Pharmacy, Amphia Hospital, Breda, The Netherlands.; Department of Pharmacy, Pharmacology & Toxicology, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands.; Otten LS; Department of Pharmacy, Pharmacology & Toxicology, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands.; Kicken MP; Department of Pharmacy, Pharmacology & Toxicology, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands.; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Piet B; Department of Pulmonary Diseases, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands.; Biesma B; Department of Pulmonary Diseases, Jeroen Bosch Hospital's, Hertogenbosch, The Netherlands.; van Veggel B; Department of Pulmonary Diseases, Jeroen Bosch Hospital's, Hertogenbosch, The Netherlands.; Steendam CMJ; Department of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands.; van den Borne B; Department of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands.; Hendriks LEL; Department of Pulmonary Diseases, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.; Croes S; Department of Clinical Pharmacy & Toxicology, CARIM-School for Cardiovascular Disease, Maastricht University Medical Centre, Maastricht, The Netherlands.; Dingemans AC; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Dumoulin DW; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Burgers JA; Department of Thoracic Oncology, Antoni Van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Huitema ADR; Department of Pharmacy & Pharmacology, Antoni Van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Derijks HJ; Department of Pharmacy, Jeroen Bosch Hospital, S-Hertogenbosch, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; van den Heuvel MM; Department of Pulmonary Diseases, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands.; Ter Heine R; Department of Pharmacy, Pharmacology & Toxicology, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Beijnen J; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Knikman JE; Div. of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Dept. of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; de With M; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands; Dept. of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Heersche N; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands; Dept. of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Lopez-Yurda M; Biometrics Dept., The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Baars A; Dept. of Medical Oncology, Hospital Gelderse Vallei, Ede, the Netherlands.; Creemers GJ; Dept. of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Droogendijk HJ; Dept. of Internal Medicine, Bravis Hospital, Roosendaal, the Netherlands.; Fiets E; Dept. of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, the Netherlands.; Imholz ALT; Dept. of Internal Medicine, Deventer Hospital, Deventer, the Netherlands.; Iersel LV; Dept. of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands.; Mandigers CMPW; Dept. of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.; van de Vendel AJ; Dept. of Medical Oncology, Hospital Gelderse Vallei, Ede, the Netherlands.; Jeurissen FJF; Dept. of Internal Medicine, Haaglanden Medical Centre, The Hague, the Netherlands.; Nieboer P; Dept. of Internal Medicine, Wilhelmina Hospital Assen, Assen, the Netherlands.; Deenen MJ; Dept. of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; van de Poel MHW; Dept. of Internal Medicine, Laurentius Hospital, Roermond, the Netherlands.; Wymenga MNM; Dept. of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.; van Schaik RHN; Dept. of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; van den Bosch BJC; Dept. Of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.; Hoop EO; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Rosing H; Dept. of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Swen JJ; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; Gelderblom H; Dept. of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Schellens JHM; Dept. of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Beijnen JH; Dept. of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Div. of Pharmacoepidemiology and Clinical Pharmacology, Dept. of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Guchelaar HJ; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; Cats A; Dept. of Gastrointestinal Oncology, Div. of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: a.cats@nki.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Fiebrich-Westra HB; Department of Oncology, Isala Hospital, Zwolle, the Netherlands.; Haroun C; Department of Clinical Pharmacy, Isala Hospital, Zwolle, the Netherlands.; Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, the Netherlands.; van der Galiën R; Department of Clinical Pharmacy, Isala Hospital, Zwolle, the Netherlands.; Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, the Netherlands.; den Besten-Bertholee D; Department of Clinical Pharmacy, Isala Hospital, Zwolle, the Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.; Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.; Bet PM; Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, the Netherlands.; de Groot JWB; Department of Oncology, Isala Hospital, Zwolle, the Netherlands.; Brohet RM; Department of Epidemiology & Statistics, Isala Hospital, Zwolle, the Netherlands.; van Kuilenburg ABP; Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Maring JG; Department of Clinical Pharmacy, Isala Hospital, Zwolle, the Netherlands.; Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Kicken MP; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands; Department of Pharmacy, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands. Electronic address: mart.kicken@catharinaziekenhuis.nl.; Ter Heine R; Department of Pharmacy, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands.; Azarfane I; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; de Rouw N; Department of Clinical Pharmacy, Amphia Hospital, Breda, The Netherlands.; de Vries F; Department of Pharmacy, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands; Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands.; Peters BJM; Department of Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein/Utrecht, The Netherlands.; Lankheet NAG; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands.; Eektimmerman F; Department of Clinical Pharmacy, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; Beerden T; Department of Clinical Pharmacy, Martini Hospital, Groningen, The Netherlands.; Franssen EJF; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands.; Krens LL; Department of Clinical Pharmacy, Maasstad Hospital, Rotterdam, The Netherlands.; van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands.; Smit AAJ; Department of Pulmonology, OLVG Hospital, Amsterdam, The Netherlands.; Polman AJ; Department of Pulmonology, Medisch Spectrum Twente, Enschede, The Netherlands.; Vermeer LC; Department of Pulmonology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; van Putten JWG; Department of Pulmonology, Martini Hospital, Groningen, The Netherlands.; van den Borne BEEM; Department of Pulmonology, Catharina Hospital, Eindhoven, The Netherlands.; van den Heuvel MM; Department of Pulmonology, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Meenks SD; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Drost-Wijnne AJA; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; van Wezel RAC; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; van Suijlekom HJA; Department of Anesthesiology, Catharina Hospital, Eindhoven, The Netherlands.; Jansen W; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Rutgers AAL; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; de Blois MW; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

Publisher: Sage Publications Country of Publication: United States NLM ID: 0043175 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0018-5787 (Print) Linking ISSN: 00185787 NLM ISO Abbreviation: Hosp Pharm Subsets: PubMed not MEDLINE

Böhm DTMM; Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Berghuis K; Obesity Center, Catharina Ziekenhuis, Eindhoven, The Netherlands.; Said M; Obesity Center, Catharina Ziekenhuis, Eindhoven, The Netherlands.; Kerskes MCHM; Department of Clinical Pharmacy, Catharina Ziekenhuis, Michelangelolaan 2, 5623, EJ, Eindhoven, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Ziekenhuis, Michelangelolaan 2, 5623, EJ, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Bastiaans DET; Department of Clinical Pharmacy, Catharina Ziekenhuis, Michelangelolaan 2, 5623, EJ, Eindhoven, The Netherlands. diane.bastiaans@catharinaziekenhuis.nl.

Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9106714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-0428 (Electronic) Linking ISSN: 09608923 NLM ISO Abbreviation: Obes Surg Subsets: MEDLINE

Ter Heine R; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands. r.terheine@radboudumc.nl.; van den Heuvel MM; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.; Piet B; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; van der Wekken AJ; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Hendriks LEL; Department of Pulmonary Diseases, GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.; Croes S; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.; CARIM School for Cardiovascular Disease, Maastricht University Medical Center+, Maastricht, The Netherlands.; van Geel RMJM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.; CARIM School for Cardiovascular Disease, Maastricht University Medical Center+, Maastricht, The Netherlands.; Jansman FGA; Department of Clinical Pharmacy, Deventer Hospital, Deventer, The Netherlands.; Unit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.; Boshuizen RC; Department of Pulmonology, Deventer Hospital, Deventer, The Netherlands.; Franssen EJF; Department of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis Hospital AC, Amsterdam, The Netherlands.; Smit AAJ; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis Hospital AC, Amsterdam, The Netherlands.; Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Oude Munnink TH; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands.; Derijks HJ; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.; Department of Pharmacy, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.; van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands.; Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands.; Moes DJAR; Department of Clinical Pharmacology and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; de Rouw N; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.; Department of Clinical Pharmacy, Amphia Hospital, Breda, The Netherlands.

Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Kerskes CHM; Department of Clinical Pharmacy, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.; van den Eijnde CJME; Department of Clinical Pharmacy, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.; Faculty of Pharmacy, University Utrecht, 3508 TB Utrecht, The Netherlands.; Aarnoudse ALHJ; Department of Nephrology and Dialysis, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.; Grouls RJE; Department of Clinical Pharmacy, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.; Deiman BALM; Department of Clinical Chemistry, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101678532 Publication Model: Electronic Cited Medium: Internet ISSN: 2226-4787 (Electronic) Linking ISSN: 22264787 NLM ISO Abbreviation: Pharmacy (Basel) Subsets: PubMed not MEDLINE

Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands. maarten.deenen@catharinaziekenhuis.nl.; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, the Netherlands. maarten.deenen@catharinaziekenhuis.nl.; van Noordenburg AJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands.; Bouwens-Bijsterveld J; Department of Clinical Chemistry, Catharina Hospital, Eindhoven, the Netherlands.; van Dijk MA; Department of Gastroenterology and Hepatology, Elkerliek Hospital, Helmond, the Netherlands.; Stapelbroek JM; Department of Pediatrics, Catharina Hospital, Eindhoven, the Netherlands.; Derijks LJJ; Department of Clinical Pharmacy, Máxima Medical Centre, Eindhoven, the Netherlands.; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Gilissen LPL; Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands.; Deiman BALM; Department of Clinical Chemistry, Catharina Hospital, Eindhoven, the Netherlands.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Electronic Cited Medium: Internet ISSN: 1473-1150 (Electronic) Linking ISSN: 1470269X NLM ISO Abbreviation: Pharmacogenomics J Subsets: MEDLINE